Scientists At Harvard University Detail Research In Prostate Cancer Therapy
Mar-26-2007
Researchers detail in "Advances in the treatment of prostate cancer," new data in prostate cancer. According to recent research from the United States, "Several recent advances have been made in the management of prostate cancer. Active surveillance is an increasingly attractive and reasonable approach for those with low-volume, low-risk disease." "For locally advanced or localized high-risk disease, neoadjuvant and adjuvant therapies are emerging as the standard of care. Innovative uses of traditional hormonal treatments can potentially limit common side effects. Recent data also support the utility of second-line hormonal therapy. For the first time, a survival advantage with the use of chemotherapy has been established. Much work is u...
Prostate Specific Antigen Velocity Threshold For Predicting Prostate Cancer In Young Men
Mar-25-2007
UroToday.com- Traditionally, a prostate biopsy has been recommended for patients with a PSA velocity of 0.75 ng/ml per year due to its increased association with prostate cancer. The relationship between PSA velocity and prostate cancer in young men has not been extensively studied. [click link for full article]
Giuliani reports clean bill of health
Mar-26-2007
Republican presidential front-runner Rudy Giuliani said Monday that his health is excellent despite battling prostate cancer in 2000.
Studies In The Area Of Prostate Cancer Therapy Reported From Johns Hopkins University
Mar-18-2007
Scientists discuss in "Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer" new findings in prostate cancer. "Prostate cancer cells, like normal prostate epithelial cells, produce high levels of the differentiation marker and serine protease prostate-specific antigen (PSA). PSA is used extensively as a biomarker to screen for prostate cancer, to detect recurrence following local therapies, and to follow response to systemic therapies for metastatic disease," investigators in the United States report. "While much is known about PSA's role as a biomarker, only a relatively few studies address the role played by PSA in the pathobiology of prostate cancer. Autopsy studies have documented that...
Alendronate Increases BMD in Men With Prostate Cancer Receiving Androgen Deprivation Therapy
Mar-22-2007
In men with nonmetastatic prostate cancer who received androgen deprivation therapy, 70 mg of alendronate once weekly prevented bone mass loss and increased bone mineral density. (CME)
Medscape Medical News
Medscape Medical News
Research From Canada, Germany And Japan Provide New Insight Into Prostate Cancer
Mar-11-2007
Studies from Canada, Germany and Japan have provided new prostate cancer data. Study 1: Researchers detail in "Prostate cancer nomograms: an update," new data in prostate cancer. According to a study from Montreal, Canada, "Several nomograms have been developed to predict outcomes related to prostate cancer (PCa). We provide a descriptive and an analytic comparison of nomograms." "Further, we report a set of recent PCa nomograms, in which we recorded predictor variables, number of patients used to develop each nomogram, and nomogram-specific features. Moreover, accuracy estimates and type of validation are considered. Our findings suggest a demand for updated nomograms in selected fields of PCa outcomes. Moreover, an increasing number...
Research On Prostate Cancer's Racial Disparities Suggests That Black Patients' Problems Are More In Access To Care Than Awareness
Mar-11-2007
Cutting death rates from prostate cancer among African-American men likely requires improving access to medical care -- not just raising awareness of the disease -- a new study of black and white prostate cancer patients in North Carolina suggests. Prostate cancer disproportionately affects African-American men, who die from the disease at more than twice the rate as their white counterparts. The new study, published today in the online version of the journal Cancer, found African-Americans are well aware of their increased risk for prostate cancer but still lag behind whites when it comes to getting regular medical checkups and screening tests that aid in early detection. African-American men also were more likely than...
Prostate Cancer Therapy May Increase Risk Of Death From Heart Disease In Older Men
Mar-11-2007
Androgen deprivation therapy -- one of the most common treatments for prostate cancer -- may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions. The study results were based on data from CaPSURE, a national registry of men with prostate cancer. Although the findings need to be confirmed in clinical trials, the study authors state that oncologists should weigh the benefits of androgen deprivation therapy, or ADT, against the risk of heart problems in older prostate cancer patients. The researchers presented their study at the Prostate Cancer Symposium in Orlando, Fla., on Saturday, Feb. 24....
Soy found protective against localized prostate cancer
Mar-14-2007
The largest study examining the relationship between the traditional soy-rich Japanese diet and development of prostate cancer in Japanese men has come to a seemingly contradictory conclusion: Intake of isoflavone chemicals, derived largely from soy foods, decreased the risk of localized prostate cancer but increased the risk of advanced prostate cancer.
Aggressive Treatment Ups Life Expectancy
Mar-11-2007
NEW YORK -- Surgery or radiation doubles the life expectancy of men with aggressive prostate cancer, a study released Friday in New York said. Researchers said that many men with aggressive prostate cancer are told that their disease is untreatable. But the study by New York-Presbyterian Hospital/Weill Cornell Medical Center found that patients with the most aggressive form of non-metastatic prostate cancer who underwent either surgery or radiation had a life expectancy of more than 14 years, compared to those who had more conservative treatment, whose life expectancy was less than seven years. "Unfortunately, pessimism abounds among many doctors, who believe that aggressive prostate cancers are beyond cure and shoul...
Soy diet's protective effects limited to localized prostate cancer
Mar-16-2007
Washington, March 16 : Japanese researchers have found that although the intake of isoflavone chemicals, derived largely from soy foods, is protective against localised prostate cancer, it increases the risk of advanced prostate cancer in men.
Health Disparities In Prostate Cancer Stem From Lack Of Care, Not Lack Of Knowledge
Mar-12-2007
Main Category: Prostate / Prostate Cancer News Article Date: 13 Mar 2007 - 0:00 PDT Decreasing the rates of prostate cancer among black men may require improving access to routine health care, rather than ...
Health Disparities In Prostate Cancer Stem From Lack Of Care, Not Lack Of Knowledge
Mar-13-2007
"This wasn't coming from some historical distrust from previous abuses but was coming from people's own experience with the health-care system"
Main Category: Prostate / Prostate Cancer News Article Date: 13 Mar 2007 - 0:00 PDT Decreasing the rates of prostate cancer among black men may require improving access to routine health care, rather than ...
National Comprehensive Cancer Network (NCCN) Prostate Cancer Guideline, Version 1.2007
Mar-13-2007
Read the most current update to the NCCN Guideline on the treatment of prostate cancer, posted on Medscape, for your convenience.
Medscape Hematology-Oncology
Medscape Hematology-Oncology
Obesity May Up Prostate Cancer Deaths
Mar-15-2007
Obesity may more than double the odds of prostate cancer death among men newly diagnosed with the disease.
Obesity Dramatically Increases Death Rate From Prostate Cancer
Mar-14-2007
Obese men who are diagnosed with prostate cancer have more than two-and-a-half times the risk of dying from the disease as compared to men of normal weight at the time of diagnosis.
Coalition to Fight Prostate Cancer touts early detection and treatment
Mar-15-2007
More Local News AUGUSTA - ' Nelson Leavitt said when he first learned he had prostate cancer, he just "shut down." The Augusta man said he had to call his doctor the next day and ask her to repeat the news to ...
Abbott to market prostate cancer screen developed by Phila. firm
Mar-12-2007
MacroArray Technologies said Monday that Abbott Laboratories will market a new test MacroArray has developed for prostate cancer.
Soya rich diet may protect you from prostate cancer
Mar-16-2007
Consuming a diet rich in soy regularly may protect you from localised prostate cancer, a study indicates although it calls for further research and well-designed clinical trials to arrive at a conclusion.
New prostate cancer fund to raise awareness
Mar-16-2007
A NEW charity designed to raise awareness of prostate cancer was due to be officially launched in the Capital today.
Adult weight gain may increase prostate cancer death risk
Mar-13-2007
Adult weight gain may increase prostate cancer death riskStaten Island Advance - These studies are important to further emphasize the importance of a healthy diet, weight management, healthy lifestyle, which in addition to helping prevent significant disease like cardiovascular disease also may be helpful in preventing death from
Obesity at time of prostate-cancer diagnosis dramatically increases risk of dying from the disease
Mar-13-2007
Obese men who are diagnosed with prostate cancer have more than two-and-a-half times the risk of dying from the disease as compared to men of normal weight at the time of diagnosis.
Prostate Cancer Survival Worse After Radiation Than Other Modalities
Mar-09-2007
Overall survival of patients with prostate cancer was worse after external-beam radiation than after treatment with implanted radioactive seeds or surgery.
Medscape Medical News
Zosia Chustecka
Medscape Medical News
Zosia Chustecka
Stopping Lung Cancer
Mar-05-2007
Dana Reeve brought attention to the disease that kills more men and women than colon, breast and prostate cancer, combined. Read to learn more about a controversial test to detect the deadly disease.
Treatment Trials for Prostate Cancer
Mar-02-2007
Trials launched to tackle killer prostate cancer
A two-year trial of treatments for prostate cancer is to begin at
Newcastle and two other universities to tackle a disease that kills about 8,500 men a year.
Prostate Cancer & You: Dr Charles "Snuffy" Myers Symposium
Mar-02-2007
The Foundation For Cancer Research and Education announced today that renowned prostate oncologist and prostate cancer survivor, Dr.
Thalidomide may slow some prostate cancers
Mar-02-2007
The drug thalidomide may slow the progression of prostate cancer in some
patients, according to premiminary research led by Dr Marcus Drake of
the School of Surgical & Reproductive Sciences.
Reactions To 'False-positive' Prostate Cancer Screenings Assessed
Mar-02-2007
Science Daily - Men who get a "false-positive" prostate cancer result -- an abnormal screening test followed by a biopsy indicating no evidence of cancer -- appear more likely to worry about their subsequent ...
Green tea found to slow prostate cancer growth
Mar-01-2007
Researchers from University of Wisconsin-Madison have found that a component of green tea, combined with low doses of Pfizer's COX-2 inhibitor Celebrex, could slow the spread of human prostate cancer.
Reactions to 'false-positive' prostate cancer screenings assessed
Mar-01-2007
Men who get a "false-positive" prostate cancer result -- an abnormal screening test followed by a biopsy indicating no evidence of cancer -- appear more likely to worry about their subsequent risk of cancer and report more problems with sexual function compared to men with normal screening results.
Tea Antioxidant Plus Celebrex May Fight Prostate Cancer
(HealthDay)
Mar-02-2007
HealthDay - FRIDAY, March 2 (HealthDay News) -- A component of green tea,
combined with low doses of the cox-2 inhibitor painkiller Celebrex, may be
able to slow prostate cancer growth, according to a U.S. study.
Active Surveillance Underutilized in Prostate Cancer
Mar-02-2007
Data from a US national registry suggest that 16% of men diagnosed with prostate cancer have low-risk disease, but only 9% of these choose active surveillance instead of immediate treatment.
Medscape Medical News
Zosia Chustecka
Medscape Medical News
Zosia Chustecka
Cytogen initiates prostate cancer study
Mar-01-2007
Cytogen Corporation has initiated a phase II study to evaluate Quadramet in combination with the therapeutic vaccine, PSA-TRICOM for patients with prostate cancer.
Tea Antioxidant Plus Celebrex May Fight Prostate Cancer
Mar-02-2007
A component of green tea, combined with low doses of the cox-2 inhibitor painkiller Celebrex, may be able to slow prostate cancer growth, according to a U.S. study.
Dendreon drug goes to FDA
Mar-01-2007
U.S. regulators assigned a review of Dendreon Corp.'s experimental prostate cancer treatment to a committee of experts on cell and gene therapies.
?13m for prostate campaign
Mar-02-2007
Ministers will today launch a ?13m drive to find an effective treatment against prostate cancer. Newcastle, Sheffield and Bristol universities are leading the seven year study involving 230,000 men
Drug Cuts Men's Prostate Risk
Mar-02-2007
June 24 - Scientists have discovered that a drug that shrinks enlarged prostates and fights baldness also cuts men's chances of getting prostate cancer.
Hume Cronyn Dead At 91
Mar-02-2007
June 17 - Hume Cronyn, the Canadian-born actor who graced the stage and silver screen for 70-years, died of prostate cancer. Cronyn was 91-years-old.
Dendreon says FDA to review Provenge submission
Mar-01-2007
Dendreon Corporation has said the FDA will review the biologics license application for Provenge, its investigational active cellular immunotherapy for the treatment of prostate cancer.